| [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 503.08 | 488.13 | 629.78 | 792.52 | 964.95 | | 同比（%） | 11.19 | (2.97) | 29.02 | 25.84 | 21.76 | | 归母净利润（百万元） | 21.72 | (61.62) | (6.44) | 18.97 | 36.09 | | 同比（%） | (32.16) | (383.69) | 89.56 | 394.71 | 90.29 | | EPS-最新摊薄（元/股） | 0.11 | (0.30) | (0.03) | 0.09 | 0.18 | | P/E（现价&最新摊薄） | 330.18 | (116.39) | (1,114.38) | 378.12 | 198.70 | [Table_Tag] [Table_Summary] 投资要点 2026 年 02 月 23 日 证券研究报告·公司深 ...

Core Viewpoint - The company reported a solid performance in 2025, driven by its "innovation + brand" dual strategy, focusing on core treatment areas and expanding its R&D pipeline while optimizing its business layout [1][2][4] Financial Performance - In 2025, the company achieved an operating income of 31.629 billion yuan, a year-on-year increase of 14.53% - The total profit reached 4.860 billion yuan, up 5.81% year-on-year - The net profit attributable to shareholders was 3.422 billion yuan, reflecting a 1.60% increase year-on-year [1] Brand Strategy - The "innovation + brand" strategy has become a core factor for the company to navigate the pharmaceutical industry's adjustment cycle and maintain stable performance - The "999" core brand remains strong, with "999 Cold Medicine" capturing a 15% market share in the common cold medication market, an increase of 0.3 percentage points from the previous year [2] R&D Investment - R&D investment has been increasing annually, from 581 million yuan in 2020 to 953 million yuan in 2024 - In the first half of 2025, R&D investment reached 662 million yuan, a 68.99% year-on-year increase, with a total of 205 projects under research [3] Product Development - The company achieved significant milestones in 2025, including the approval of its first traditional Chinese medicine class 3.2 new drug, "999 Yiqi Qingfei Granules," which entered the national medical insurance drug list - The company has received five production approvals for class 3.1 traditional Chinese medicine formulations, maintaining an industry-leading position [3] M&A Strategy - The company has successfully implemented an external acquisition strategy, acquiring significant assets such as Kunming Pharmaceutical Group and Tianjin Tasly, which has helped expand its business footprint and create a "one body, two wings" business model [4][5] - The collaboration among the three listed companies has led to clear division of labor and synergistic development [4] Future Outlook - The company plans to deepen the "one body, two wings" strategy internally while continuously seeking acquisition targets in consumer health, medical health, and silver economy sectors externally - The focus will be on new products, new technologies, and high clinical value opportunities to support innovation and development strategies [6]

Group 1: Business Model and Operations - The company's operation and maintenance (O&M) business employs a dual-driven model, focusing on equipment maintenance and production line management to enhance customer productivity and operational efficiency [2][3] - The core of the company's smart O&M is the integration of "data + algorithms," utilizing AI, manufacturing, and process application technologies to achieve predictive maintenance and remote diagnostics [2][3] Group 2: Market Position and Competition - The main competitors in the smart O&M sector include overseas manufacturers with insufficient service coverage, domestic large mining enterprises focused on their own projects, and local peers emphasizing overall management rather than the integration of equipment, services, and intelligence [3] - The company differentiates itself by combining equipment, services, and smart technology, enhancing product recovery rates and value for customers [3] Group 3: Strategic Transition and Equipment Layout - The transition from aggregate to metal mining business requires higher precision in ore crushing and aims for high recovery rates and low impurities [4] - The company is enhancing its equipment layout by investing in technology firms and establishing new facilities to strengthen its operational capabilities [4] Group 4: Resource Business and Investment Principles - The resource business strategy focuses on gold and copper, avoiding high-risk greenfield projects and those with uncertain returns [5] - The company aims to partner with small to medium-sized quality mines to secure operational rights and sales channels, rather than relying on mineral dividends [5] Group 5: Overseas Market Strategy - The "Three Transfers and One Optimization" strategy emphasizes expanding overseas, mining, and aftermarket services while optimizing the aggregate business structure [6] - The goal is to increase overseas revenue to 70%, addressing challenges such as the lack of experienced sales personnel by transitioning domestic talent to international markets [6] Group 6: Talent Development and Capacity Building - The year 2026 is designated as the "Year of Capacity Building," focusing on recruiting professionals in geology, mining, and metallurgy to strengthen the talent pool [7] - The company plans to enhance its technical capabilities through the establishment of experimental facilities and laboratories, ensuring alignment with business objectives [7]

Group 1 - The company, Nanmin Group, approved an investment of $30 million to acquire a 10% stake in Eagle Canyon Gold Limited through its wholly-owned subsidiary, NMS International Holding Pte. Ltd [1] - The final share acquisition will be determined based on third-party audits and asset evaluations of Eagle Canyon Gold Limited [1] Group 2 - Eagle Canyon Gold Limited plans to restructure internally to gain control over Ever Rising Resources (Private) Limited, Gritmine Minerals (Private) Limited, and Pan African Mining (PVT) Ltd, facilitating the consolidation of their financial statements [2] - Pan African Mining holds 100% mining rights to several gold projects in Zimbabwe, including Ayrshire, Muriel, and Three Cheers [2] Group 3 - This external investment aligns with the company's operational strategy of "three transformations and one optimization" and aims to enhance its core business advantages [3] - By acquiring equity in Eagle Canyon Gold Limited, the company aims to gain rights to mineral resources and priority cooperation on related mining projects, injecting new growth momentum into its existing operations [3] - The investment will enable the company to extend its business from traditional equipment sales to broader mining operation services, tapping into the potential of a diversified business ecosystem [3]

Group 1 - The company, Nanmin Group, approved an investment of $30 million to acquire a 10% stake in Eagle Canyon Gold Limited through its wholly-owned subsidiary, NMS International Holding Pte. Ltd [1] - The final share acquisition will be determined based on third-party audits and asset evaluations of Eagle Canyon Gold Limited [1] - This investment aligns with the company's strategic focus on transitioning its operations and expanding into overseas markets and resource investments [3] Group 2 - Eagle Canyon Gold Limited plans to restructure its operations to gain control over Ever Rising Resources (Private) Limited, Gritmine Minerals (Private) Limited, and Pan African Mining (PVT) Ltd, facilitating financial consolidation [2] - Pan African Mining holds 100% mining rights to several gold projects in Zimbabwe, including Ayrshire, Muriel, and Three Cheers [2] - The investment will enhance the company's core business and provide new growth momentum by extending its services into mining operations [3]

Core Insights - The company, Zhonggong International, has demonstrated strong operational performance in 2025, achieving record highs in new contracts and effective contracts despite challenging economic conditions [1][2]. Group 1: Financial Performance - In Q4 2025, the company reported total revenue of approximately 4.283 billion yuan and operating profit of about 164 million yuan, showing significant year-on-year and quarter-on-quarter growth [2]. - The net cash flow from operating activities reached 882 million yuan, a remarkable increase of 207.13% year-on-year, primarily driven by successful project implementations [2]. Group 2: Contract Achievements - The total new contract value for 2025 was 3.532 billion USD, marking a year-on-year increase of 4.19% and setting a historical record [3]. - The international engineering business saw significant growth, with 17 major contracts signed, totaling 2.106 billion USD, and effective contract value reaching 1.880 billion USD, up 62.91% year-on-year [3]. Group 3: Sector Focus and Competitive Advantages - The company is focusing on specialized sectors, particularly in healthcare, oil and gas, and industrial construction, establishing a competitive edge through its business model [4][5][6]. - In the healthcare sector, the company signed contracts for projects in Iraq and Guyana, reinforcing its brand presence and customer satisfaction [4]. - In the oil and gas sector, key projects include the Turkish Tuz Lake gas storage phase three and the Iraqi SIBA gas field project, enhancing the company's footprint in the Middle East [5]. - The industrial construction sector is also thriving, with significant projects in Nicaragua and Kazakhstan, aligning with both domestic and international industrialization demands [6].

Core Viewpoint - Guoen Technology Co., Ltd. is set to achieve a dual listing in Hong Kong after passing the main board listing hearing, aiming to enhance its "chemical new materials + health" dual business strategy and accelerate overseas capacity layout [1][4]. Group 1: Business Strategy - The company has established a unique "one body, two wings" business structure, leveraging vertical integration to create significant scale advantages [1]. - In the chemical sector, Guoen is the second-largest supplier of organic polymer modified materials and organic polymer composite materials in China, with a market share of approximately 2.5% as of 2024 [1]. - The health segment, through its subsidiary Dongbao Biological, has formed a complete closed loop in the collagen industry, benefiting from domestic substitution and consumption upgrades [2]. Group 2: Financial Performance - Guoen has demonstrated robust revenue growth, with a compound annual growth rate (CAGR) of 19.6% from fiscal year 2022 to fiscal year 2024, achieving revenues of RMB 134.06 billion, RMB 174.39 billion, and RMB 191.88 billion respectively [3]. - The company recorded revenue of RMB 174.44 billion in the first ten months of fiscal year 2025, continuing its stable growth trajectory [3]. - The combination of stable chemical business and high-barrier health business enhances overall operational resilience and profitability [3]. Group 3: Future Outlook and Expansion Plans - The company plans to establish a new production base in Thailand to better serve overseas customers and mitigate trade barriers [4]. - Domestic capacity expansion is planned in Yixing, Jiangsu, to further consolidate market share [5]. - A regional headquarters will be set up in Hong Kong to deepen global research and development and capital operations [6].

Core Insights - Wanlian Asset Management has achieved a significant milestone by surpassing 50 billion yuan in total asset management scale within just over two years since its establishment in 2023, reflecting its successful differentiation and specialization in the industry [1][2] Group 1: Business Growth and Strategy - Wanlian Asset Management has positioned itself as the first licensed financial institution approved to settle in Nansha since the implementation of the Nansha Plan, leveraging its shareholder resources and professional advantages to meet local economic needs [2] - The company has successfully doubled its asset management scale by focusing on the development opportunities presented by the Greater Bay Area and the Nansha cross-border asset management center [1][2] - The firm has issued 12 medium to long-term "fixed income plus" products in the current year, catering to investors with moderate risk tolerance and enhancing its growth engine [3] Group 2: Product Development and Client Focus - Wanlian Asset Management has launched its first equity product, establishing a series of equity products that cover various strategies, effectively addressing the asset allocation needs of high-risk preference clients [3] - The company emphasizes a client-centric approach, innovating investment strategies and expanding its product matrix to better serve the elderly demographic, with 66% of high-net-worth clients aged 50 and above [4] - The firm has issued over 270 private collective products, with several fixed income products ranking first in their category since inception, demonstrating its commitment to delivering value to clients [4] Group 3: Future Outlook - Moving forward, Wanlian Asset Management aims to deepen its transformation through a specialized and high-quality approach, enhancing its financial service capabilities and contributing to the construction of an international financial hub in the Greater Bay Area [5]

Core Viewpoint - Haitong International expects Hu Shang Ayi (02589) to achieve revenues of 4.22 billion, 4.92 billion, and 5.63 billion CNY for the years 2025-2027, with adjusted net profits of 540 million, 620 million, and 710 million CNY respectively, assigning a target price of 105 HKD based on a 16X PE valuation for 2026, and initiating coverage with an outperform rating [1] Group 1: Company Overview - Hu Shang Ayi is a leading fresh beverage company in China, projected to surpass 10,000 stores by the end of 2025, becoming the third fresh tea beverage brand in the country to achieve this milestone [2] - The company is leveraging its scale and channel advantages to strengthen its position in the market, as the window for new brands to rapidly scale has closed, leading to a landscape where strong brands will dominate [2] Group 2: Business Strategy - The company operates with a "one body, two wings" business model, focusing on Hu Shang Ayi in China and the Tea Waterfall brand along with overseas markets as growth drivers [3] - Hu Shang Ayi's rapid expansion is attributed to its effective management philosophy, which emphasizes mutual benefits and resource sharing, as well as a focus on health-oriented products targeting specific customer demographics [3] - The company has established a low-threshold store model and an inclusive franchise system, which allows for sustainable expansion through new franchisee investments and improved single-store profitability [3] Group 3: Growth Engines - The Tea Waterfall brand is designed for lower-tier markets, creating a distinct identity while benefiting from the main brand's resources, while overseas expansion targets developed markets with successful store openings [4] - Both channel penetration and international expansion are seen as correct strategic directions for the brand, with significant potential for growth as these initiatives are still in their early stages [4] Group 4: Financial Forecast - The company is expected to stabilize its market share with over 2,000 new Hu Shang Ayi stores and over 1,000 new Tea Waterfall stores by 2026, with same-store sales expected to remain stable despite high bases due to delivery subsidies in 2025 [5]

Core Insights - Country Garden Holdings has prioritized "guaranteeing housing delivery" as a fundamental aspect of its survival and development strategy, achieving the delivery of nearly 170,000 homes in 2025 and a cumulative total of approximately 1.85 million homes since 2022, maintaining its leading position in third-party rankings [1] - The company has made significant progress in debt restructuring, with no defaults reported on domestic public market bonds and a formalized offshore debt restructuring plan involving approximately $17.7 billion, which has alleviated substantial debt burdens and is seen as a critical step towards renewal [1] - The controlling shareholder family has committed to supporting the company through challenges, emphasizing the importance of "guaranteeing housing delivery" as a top priority and actively coordinating efforts to manage debt and ensure housing delivery [1] Future Strategy - The company plans to transition its operational focus from the critical phase of "guaranteeing housing delivery" to the ongoing optimization of its debt structure and the restoration of normal business operations, leveraging the achievements of its debt restructuring as a new starting point [2] - Under the new strategic framework of "one body and two wings," the company aims to explore new development models in real estate, with the "one body" focusing on real estate as the mainstay and the "two wings" encompassing technology construction and property management services [2] - The company intends to integrate into national development strategies by exploring the fusion of green technology, smart construction, and new industries such as AI and renewable energy within its core real estate business [2]